Skip to main content

With 7.3% CAGR, Infusion Pump Market Size Worth USD 15.81 Billion by 2028

According to Fortune Business Insights, the global infusion pump market size is projected to reach USD 15.81 billion in 2028, at a CAGR of 7.3% during the forecast period, 2021-2028

Pune, India, Nov. 29, 2022 (GLOBE NEWSWIRE) — The infusion pump market size was USD 9.02 billion in 2020. The market is projected to grow from USD 9.67 billion in 2021 to USD 15.81 billion in 2028 at a CAGR of 7.3% during the 2021-2028 period. The market stood at advancements in drug delivery systems, increasing prevalence of chronic disorders, and rising development and research initiatives are anticipated to boost the market growth. Fortune Business Insights™, present this vital information in its report titled, “Infusion Pump Market, 2021-2028.”

Industry Development

April 2021- Medtronic has launched world’s first and only infusion set that can be used for up to seven days in select European countries. This set is responsible for delivering insulin from the pump into the human body. This new set is compatible with all MiniMed 600 and 700 series insulin pumps.


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/infusion-pump-market-102554


Report Scope:

Report CoverageDetails
Forecast Period2021 to 2028
Forecast Period 2021 to 2028 CAGR7.3%
2028 Value ProjectionUSD 15.81 Billion
Base Year2020
Market Size in 2021USD 9.67 Billion
Historical Data2017 to 2019
No. of Pages135
Segments coveredTypes, Application, end-Users and Geography


Robust Demand for Pumps from Healthcare Sector to Boost Market Growth

This market will experience promising growth during the COVID-19 pandemic due to the increasing demand from the healthcare sector. The sudden spike in COVID-19 patients leads to the emergence of several organ failures, which, in turn, is likely to boost sales. The adoption of reduced capacities, part-time shifts, and production machinery may enable manufacturers to recover losses and balance costs. Furthermore, the rising medical expenditures and demand for advanced medical equipment are likely to boost the adoption of the product. These factors are likely to fuel the market development during the pandemic.


Click here to get the short-term and long-term impact of COVID-19 on this market: https://www.fortunebusinessinsights.com/infusion-pump-market-102554 




Growing Cases of Cancer and Diabetes to Aid Market Expansion

The increasing incidence of cancer among patients will spur opportunities for the infusion pumps market during the forecast period. According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the infusion pumps. Moreover, the knowledge about the advantages of infusion pumps such as the ability to administer fluids in small dosage and at accurate programmed rates will promote the infusion pumps market revenue.

Market Segmentation:

Segmentation of Infusion Pump MarketBy Type

  • Volumetric Pumps
  • Syringe Pumps
  • Elastomeric Pumps
  • Insulin Pumps
  • Enteral Pumps
  • Implantable Pumps
  • Patient Control Analgesia (PCA) Pumps
By Application

  • Diabetes
  • Oncology
  • Pain Management
  • Others
By End User

  • Hospitals
  • Ambulatory Care Settings
  • Specialty Clinics
  • Home Care Settings


Quick Buy – Infusion Pump Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102554


Favorable Reimbursement Policies to Stoke Market Growth in North America

North America is projected to dominate the infusion pump market share because of favorable reimbursement policies. The market in North America stood USD 3.52 billion in 2020 and is expected to grow positively during the upcoming years. Further, higher diagnosis and treatment rates are likely to boost infusion pumps’ adoption. In addition, the presence of developed medical infrastructure and rising diabetes treatment rates may boost industry growth.

Europe is the second-largest market shareholder because of rising investments in healthcare sectors and increasing chronic diseases. In addition, rising medical expenditure and evolving lifestyles may facilitate industry development.

In Asia Pacific, rising diabetes cases, rising per-capita income, healthcare infrastructure development, and rising awareness regarding the benefits of advanced therapies may boost market development.

List of Key Players Profiled in the Infusion Pumps Market Report

  • Medtronic (Ireland)
  • Becton Dickinson and company (U.S.)
  • Baxter (U.S.)
  • Insulet Corporation (U.S.)
  • ICU Medical, Inc. (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Smiths Medical (Smiths Group plc.) (U.S.)
  • Fresenius Kabi AG (Germany)
  • Terumo Corporation (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

 

Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/infusion-pump-market-102554


Detailed TOC:

  • Introduction
  • Executive Summary
  • Market Dynamics
  • Key Insights
  • Global Infusion Pump Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Volumetric Pumps
      •  Syringe Pumps
      • Elastomeric Pumps
      • Insulin Pumps
      • Enteral Pumps
      • Implantable Pumps
      • Patient Control Analgesia (PCA) Pumps
    • Market Analysis, Insights and Forecast – By Application
      • Diabetes
      • Ambulatory Care Settings
      • Pain Management
      • Others
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Ambulatory Care Settings
      • Specialty Clinics
      • Home Care Settings
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Infusion Pump Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis – By Type
      • Volumetric Pumps
      •  Syringe Pumps
      • Elastomeric Pumps
      • Insulin Pumps
      • Enteral Pumps
      • Implantable Pumps
      • Patient Control Analgesia (PCA) Pumps
    • Market Analysis – By Application
      • Diabetes
      • Ambulatory Care Settings
      • Pain Management
      • Others
    • Market Analysis – By End User
      • Hospitals
      • Ambulatory Care Settings
      • Specialty Clinics
      • Home Care Settings
    • Market Analysis – By Country
      • U.S.
        • By Type
          • Volumetric Pumps
          •  Syringe Pumps
          • Elastomeric Pumps
          • Insulin Pumps
          • Enteral Pumps
          • Implantable Pumps
        • Patient Control Analgesia (PCA) Pumps
      • Canada
        • By Type
          • Volumetric Pumps
          •  Syringe Pumps
          • Elastomeric Pumps
          • Insulin Pumps
          • Enteral Pumps
          • Implantable Pumps
          • Patient Control Analgesia (PCA) Pumps
  • Europe Infusion Pump Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary

TOC Continued…….


Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/customization/infusion-pump-market-102554


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.